Skip to main content

Table 2 Serum visfatin levels [shown as medians and (Q1–Q3)] according to the vascular territory affected

From: Association between serum visfatin levels and atherosclerotic plaque in patients with type 2 diabetes

ParametersVisfatin (ng/mL)
No plaque (n = 41)0.45 (0.23–0.76)
Carotid plaques (n = 20)2.37 (0.74–6.27)a,b,c
Femoral plaques (n = 20)0.49 (0.38–0.66)
Both carotid and femoral plaques (n = 16)0.68 (0.55–1.25)a,b
  1. aP < 0.01 versus No plaque group
  2. bP < 0.05 versus femoral plaques group
  3. cP < 0.05 versus both carotid and femoral plaques group (Mann–Whitney U test)